Biomarkers of Acute Coronary Syndrome and Heart Failure
Product ID: 4671
NACB Laboratory Medicine Practice Guidelines
This LMPG provides analytical and clinical guidance for the measurement and interpretation of biochemical markers of cardiac injury in acute coronary syndromes (ACS) and heart failure. Also included are recommendations for point-of-care measurement and logistics of providing ACS biomarker testing for patient care as well as guidance for interpretation of cardiac biomarkers in etiologies other than ACS and Heart Failure. The recommendations are based upon the best available evidence and consensus of expert contributors and reviewers.